Epstein-Barr virus-associated gastric adenocarcinomas among Koreans

American Journal of Clinical Pathology

Volumn 105, Issue 2, 1996, Pages 174-181

  Shin, Wan Shik ^a   Kang, Moon Won ^a   Kang, Jin Han ^a   Choi, Myung Kyu ^a   Ahn, Byung Min ^a   Kim, Jae Kwang ^a   Sun, Hee Sik ^a   Min, Kyung Whan ^b,c  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c Deaconess Hospital Oklahoma City   (United States)

Author keywords

Epstein Barr virus; Gastric carcinoma; Gastric neoplasms; Immunohistochemistry; In situ hybridization

Indexed keywords

ARTICLE; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; KOREA; LYMPHOCYTIC INFILTRATION; LYMPHOID CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; RNA SEQUENCE; STOMACH ADENOCARCINOMA; VIRUS EXPRESSION; VIRUS GENOME;

EID: 0041101081     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.2.174     Document Type: Article

References (34)

1. Burke AP, Yen TS, Shekitka KM, Sobin LH. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 1990;3:377-380.
2. Min K-W, Holmquist S, Pieper SC, O'Leary TJ. Poorly differentiated adenocarcinoma with lymphoid stromal (lymphoepithelioma-like carcinomas) of the stomach: Report of three cases with Epstein-Barr virus genome demonstrated by the polymerase chain reaction. Am J Clin Pathol 1991;96:219-227.
3. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration: Lymphoepithelioma-like carcinoma. Am J Pathol 1991;139:469-474.
4. Nakamura S, Ueki T, Yao T, Ueyama T, Tsuneyoshi M. Epstein-Barr virus in gastric carcinoma with lymphoid stroma: Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. Cancer 1994;73:2239-2249.
5. Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992;140:769-774.
6. Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E. Epstein-Barr virus in gastric carcinoma. Am J Pathol 1993;143:1250-1254.
7. Yuen ST, Chung LP, Leung SY, Luk IS, Chan SY, HO J. In situ detection of Epstein-Barr virus in gastric and cholorectal adenocarcinomas. Am J Surg Pathol 1994;18:1158-1163,
8. Miller G. Epstein-Barr virus: Biology, pathogenesis, and medical aspects. In: Fields, BN, Knipe DM, eds. Virology, ed 2. New York: Rabin Press, 1990, pp 1921-1958.
9. Wang F, Gregory C, Sample C, et al. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol 1990;64:2309-2318.
10. Fahraeus R, Chen W, Trivedi P, Klein G, Obrink B. Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transected human epithelial and murine adenocarcinoma cells. Int J Cancer 1992;52:834-838.
11. Fahraeus R, Rymo L, Rhim JS, Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 1990;345:447-449.
12. Cooper NR, Bradt BM, Rhim JS, Nemerow GR. CR2 complement receptor. J Invest Dermatol 1990;94:112S-117S.
13. American Joint Committee for Cancer Staging and End-results Reporting. Manual for Staging of Cancer. Chicago: American Joint Committee, 1977.
14. Montone KT, Budgeon LR, Brigati DJ. Detection of Epstein-Barr virus genomes by in situ DNA hybridization with a terminally biotin-labeled synthetic oligonucleotide probe from the EBV NOT I and PST I tandem repeat regions. Mod Pathol 1990;3: 89-96.
15. Reed JA, Manahan LJ, Park C-S, Brigati DJ. Complete 1-hour immunocytochemistry based on capillary action principle. Biotechniques 1992;13:434-442.
16. Iezzoni JC, Gaffey MJ, Weiss LM. The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas. Am J Clin Pathol 1995;103:308-315.
17. Rowlands DC, Ito M, Mangham DC, et al. Epstein-Barr virus and carcinomas: Rare association of the virus with gastric adenocarcinomas. Br J Cancer 1993;68:1014-1019.
18. Leoncini L, Vindigni C, Megha T, et al. Epstein-Barr virus and gastric cancer: Data and unanswered questions. Int J Cancer 1993;53:898-901
19. Shousha S, Luqmani YA. Epstein-Barr virus in gastric carcinoma and adjacent gastric and duodenal mucosa. J Clin Pathol 1994;47:695-698.
20. Manivel JC, Jessurun J, Bolio A, McMahon E, Horwitz C. Epstein-Barr virus (E-BV) in gastric adenocarcinoma and lymphoid cells: Comparative study between two different populations. Mod Pathol 1994;6:64A.
21. Tokunaga M, Uemura Y, Tokudome T, et al. Epstein-Barr virus related gastric cancer in Japan: A molecular patho-epidermiological study. Acta Pathol Jap 1993;43:574-581.
22. Mon M, Watanabe M, Tanaka S, Mimori K, Kuwano H, Sugimachi K. Epstein-Barr virus-associated carcinomas of the esophagus and stomach. Arch Pathol Lab Med 1994;118:998-1001.
23. Harn H-J, Chang J-Y, Wang M-W, et al. Epstein-Barr virus associated gastric adenocarcinoma in Taiwan. Hum Pathol 1995;26: 267-271.
24. Fukayama M, Hayashi Y, Iwasaki Y, et al. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest. 1994, 71:73-81.
25. Yuen ST, Chung LP, Leung SY, Luk IS, Chan SY, Ho J. In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas. Am J Surg Pathol 1994;18:1158-1163.
26. De-The G. Epidemiology of Epstein-Barr Virus and Associated Diseases in Man. In: Roizman B, ed. The Herpes Viruses, vol 1. New York: Plenum, 1982, pp 25-87.
27. Gaffey MJ, Weiss LM. Viral oncogenesis: Epstein-Barr virus. Am J Otolaryngol 1990;11:375-381.
28. Pittaluga S, Loke L, So KC, Cheung KN, Ma L. Clonal Epstein-Barr virus in lymphoepithelioma-like carcinoma of the stomach: Demonstration of viral genome by in situ hybridization and Southern blot analysis. Mod Pathol 1992;5:661-664.
29. Ott G, Kirchner TH, Muller-Hermelink HK. Monoclonal Epstein-Barr virus genomes but lack EBV-related protein expression in different types of gastric carcinoma. Histopathology 1994;25: 323-329.
30. Niedobitek G, Fahraeus R, Herbst H, et al. The Epstein-Barr virus encoded membrane protein (LMP) induces phenotypic changes in epithelial cells. Virchows Arch B Cell Pathol 1992;62:55-59.
31. Kaye KM, Izumi KM, Kieff E. Epstein-Barr virus latent membrane protein-1 is essential for B-lymphocytes growth transformation. Proc Natl Acad Sci USA 1993;90:9150-9154.
32. Dawson CW, Rickinson AB, Young LS. Epstein-Barr virus latent membrane protein inhibits human epithelial differentiation. Nature 1990;344:777-780.
33. Dawson CW, Rickinson AB, Young LS. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 1990;344:777-780.
34. Min K-W, Kang M-W, Shin W-S, Kim J-K, Kang J-H, Shin S-I. Epstein-Barr (EBV) associated gastric carcinomas (EBVaGC): Histopathologic characteristics and p53 and epidermal growth factor receptor (EGFR) expression. Mod Pathol 1995;8:65A (Abstr).